EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Community pharmacists’ knowledge of, and role in, managing anticholinergic burden among patients with dementia in primary care: a cross-sectional survey study

Bara'a Shawaqfeh, Carmel M Hughes, Bernadette McGuinness, Heather E Barry

International Journal of Clinical Pharmacy · 2025

DOI: 10.1007/s11096-024-01831-w ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift International Journal of Clinical Pharmacy, 2025. Verfasst von Bara'a Shawaqfeh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Primary Care Research Group, School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, UK. Hauptthemen laut MEDLINE: Dementia, Cholinergic Antagonists, Pharmacists, Professional Role. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Al-Zaytoonah University of Jordan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Anticholinergic medications and associated anticholinergic burden can impair cognitive function and increase mortality rates in patients with dementia.

Aim

To explore community pharmacists’ knowledge of anticholinergic burden and perceptions of their role in anticholinergic burden management amongst patients with dementia.

Method

A self-administered, postal questionnaire was distributed to all registered community pharmacies in Northern Ireland (n = 526) on two occasions (October and November 2022). The questionnaire comprised four sections: (1) demographics associated with pharmacists and pharmacies, (2) contact between community pharmacists and patients with dementia/their carers, and types of medication-related queries received by pharmacists, (3) understanding and knowledge about anticholinergic burden, and (4) community pharmacist role in management of anticholinergic burden in patients with dementia. Data were analysed descriptively using Stata v17.

Results

A response rate of 15.2% (80/526) was achieved. Most contact was with patients with dementia/carers in their own homes. Community pharmacists lacked knowledge about anticholinergic burden in dementia, did not use any anticholinergic burden scales in their practice (n = 77, 96.3%), and rarely discussed anticholinergic burden with patients, carers (n = 60, 75.0%), or other healthcare professionals (n = 42, 52.5%). However, they were positive about their role in future interventions and saw value in managing anticholinergic burden in patients with dementia as part of a multidisciplinary primary healthcare team (n = 67; 83.3%).

Conclusion

Despite the low response rate, the study findings have highlighted community pharmacists’ willingness to contribute to the management of anticholinergic burden in patients with dementia. Further research is required to understand how this can be achieved.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DementiaCholinergic AntagonistsPharmacistsProfessional RoleCommunity Pharmacy ServicesPrimary Health CareHealth Knowledge, Attitudes, PracticeHumansCross-Sectional StudiesMaleFemaleSurveys and QuestionnairesMiddle AgedAgedNorthern IrelandAdult

Stichwörter der Autor:innen

Anticholinergic burdenCommunity pharmaciesCross sectional surveyDementiaPharmacists

Substanzen

Cholinergic Antagonists

Autor:innen und Institutionen

  • Primary Care Research Group, School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, UK.
  • Faculty of Pharmacy, AL-Zaytoonah University of Jordan, Amman, Jordan.
  • Centre for Public Health, Institute of Clinical Sciences, Royal Victoria Hospital, Queen's University Belfast, Belfast, BT12 6BA, UK.
  • Primary Care Research Group, School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, UK. H.Barry@qub.ac.uk.

Förderung

  • Al-Zaytoonah University of Jordan

Zitieren

APA

Shawaqfeh, B., Hughes, C. M., McGuinness, B., & Barry, H. E. (2025). Community pharmacists’ knowledge of, and role in, managing anticholinergic burden among patients with dementia in primary care: a cross-sectional survey study. International Journal of Clinical Pharmacy. https://doi.org/10.1007/s11096-024-01831-w

Vancouver

Shawaqfeh B, Hughes CM, McGuinness B, Barry HE. Community pharmacists’ knowledge of, and role in, managing anticholinergic burden among patients with dementia in primary care: a cross-sectional survey study. International Journal of Clinical Pharmacy. 2025. doi:10.1007/s11096-024-01831-w

BibTeX
@article{Shawaqfeh2025,
  author = {Shawaqfeh, Bara'a and Hughes, Carmel M and McGuinness, Bernadette and Barry, Heather E},
  title = {Community pharmacists’ knowledge of, and role in, managing anticholinergic burden among patients with dementia in primary care: a cross-sectional survey study},
  journal = {International Journal of Clinical Pharmacy},
  year = {2025},
  doi = {10.1007/s11096-024-01831-w}
}
Kostenlos starten →